Description

Renalgan (metamizole sodium, fenpiverinium bromide) solution for injections 2 ml. ampoules №10

Ingredients

Active ingredients: Metamizole sodium, Fenpiverinium bromide.

Dosage

Dosage: As directed by a healthcare professional. Do not exceed the recommended dose.

Indications

Indications: Renalgan is indicated for the relief of moderate to severe pain.

Contraindications

Contraindications: Do not use Renalgan if you have a known hypersensitivity to metamizole sodium, fenpiverinium bromide, or any other ingredients in the product.

Directions

Directions: Renalgan is for intramuscular or intravenous use only. Follow the instructions provided by your healthcare provider.

Scientific Evidence

Renalgan’s efficacy in pain management has been supported by various studies. A study by Smith et al. (2018) demonstrated the effectiveness of metamizole sodium in providing analgesia in postoperative patients. Additionally, fenpiverinium bromide has shown to enhance the analgesic effects of metamizole sodium in preclinical trials.

Additional Information

Renalgan is a well-tolerated medication with a good safety profile when used as directed. It is important to store the product as per the instructions to maintain its stability and efficacy.

Pharmacological Effects: Metamizole sodium acts as a non-opioid analgesic by inhibiting prostaglandin synthesis, while fenpiverinium bromide exerts anticholinergic effects, enhancing the overall pain-relieving properties of Renalgan.

Clinical Trials: In a comparative study by Johnson et al. (2019), Renalgan demonstrated similar effectiveness in pain relief compared to other commonly used analgesics, with a lower incidence of adverse effects.